Neurological Outcome in Patients of Traumatic Subarachnoid Haemorrhage
NCT ID: NCT02073890
Last Updated: 2014-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
117 participants
OBSERVATIONAL
2012-09-30
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital
NCT06560372
Cerebrospinal Fluid Hemoglobin to Monitor for Aneurysmal Subarachnoid Hemorrhage Related Secondary Brain Injury
NCT04998370
Blood Pressure Treatment in ICU Patients with Subarachniodal Haemorrhage.
NCT06033378
Radiological Changes of Glymphatic-meningeal Lymphatic Drainage System After Subarachnoid Hemorrhage
NCT06444438
Hidden Impairments During Subarachnoid Haemorrhage Recovery, Description and Evolution of a Newly Described Syndrom
NCT06276517
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
traumatic subarachnoid haemorrhage
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Altered coagulation profile
* Cardiac disease
* Co- morbid illness
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Center for Applied Research & Education
UNKNOWN
SMS Medical College and Hospital
UNKNOWN
Macmillan Research Group UK
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neha Sharma, PhD
Role: STUDY_CHAIR
Macmillan Research Group UK
Virendra D Sinha, M Ch
Role: STUDY_DIRECTOR
SMS Medical College & Hospital, Jaipur
Manish Agrawal, M Ch
Role: PRINCIPAL_INVESTIGATOR
SMS Medical College & Hospital, Jaipur
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CARE 1021/14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.